Press "Enter" to skip to content

Marken doubles capacity of Frankfurt cold-chain facility

By growing the dimensions of its Frankfurt, Germany, facility (slated to go surfing in October) to greater than 40,000 sq. toes, Marken is growing its frozen-room storage capabilities and accommodating extra purchasers seeking to transport and retailer cell and gene remedy options. Outsourcing-Pharma (OSP) not too long ago spoke with Marken president Ariette van Strien (AVS) in regards to the GMP-certified facility, the trade’s evolving cold-storage calls for and the way COVID-19 is impacting the enterprise.

OSP: Could you please share the historical past of the Marken GMP community – when was it launched, storage/logistics capabilities there, the way it’s advanced through the years, and many others.

AVS: Marken has constructed and operated a completely GMP compliant owned community of 10 depots for the final decade, and these are additionally supplemented by choose accomplice depots in different key places all over the world.  This community continues to develop with plans to open Los Angeles (USA) and Kiev (Ukraine) within the coming months.

Each depot is constructed after an in depth evaluation of consumer calls for in addition to geographical wants, permitting scientific trials to be carried out in a price environment friendly and optimized method. These central depots enable us to serve our purchasers with complete and environment friendly world distribution companies for his or her scientific drug merchandise and ancillary companies; they’re constructed to pharmaceutical manufacturing requirements and are absolutely GMP compliant.

Depots are normally co-located with our logistics hubs so as to take benefit of well-established customer support, operations import /export and administrative assist. Each of Marken’s depots are linked by the Solo platform, a worldwide state-of-the-art, 21 CFR half 11 validated, cloud-based stock administration system which might interface with IRT for improved stock reconciliation.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *